Edition:
United States

Bliss GVS Pharma Ltd (BLIS.NS)

BLIS.NS on National Stock Exchange of India

150.75INR
1:14am EST
Change (% chg)

Rs0.30 (+0.20%)
Prev Close
Rs150.45
Open
Rs149.00
Day's High
Rs153.80
Day's Low
Rs148.05
Volume
362,645
Avg. Vol
199,006
52-wk High
Rs220.25
52-wk Low
Rs125.00

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Mar-18 1 8,638.00 8,638.00 8,638.00 --
Earnings (per share)
Year Ending Mar-18 1 10.00 10.00 10.00 --
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.45 30.88
P/E High - Last 5 Yrs. 1,099.37 41.60 46.69
P/E Low - Last 5 Yrs. 11.32 25.00 25.78
Beta 0.73 0.98 0.95
Price to Sales (TTM) 4.78 19.89 21.76
Price to Book (MRQ) 2.80 4.30 4.53
Price to Tangible Book (MRQ) 2.84 12.11 11.76
Price to Cash Flow (TTM) 32.59 21.70 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield 0.61 1.68 1.60
Dividend Yield - 5 Year Avg 0.49 1.49 1.42
Dividend 5 Year Growth Rate 7.39 -11.45 -8.76
Payout Ratio(TTM) 39.01 46.02 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 0.83 4.36 6.54
Sales (TTM) vs TTM 1 Yr. Ago -35.52 3.97 5.26
Sales - 5 Yr. Growth Rate -1.25 7.07 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago -18.48 22.48 22.50
EPS (TTM) vs TTM 1 Yr. Ago -110.95 -- --
EPS - 5 Yr. Growth Rate -49.77 6.71 7.64
Capital Spending - 5 Yr. Growth Rate 8.00 8.06 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.67 2.65 2.63
Current Ratio (MRQ) 2.97 3.71 3.68
LT Debt to Equity (MRQ) 2.16 7.50 9.53
Total Debt to Equity (MRQ) 14.39 10.94 13.39
Interest Coverage (TTM) 6.84 40.82 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 23.77 51.06 50.91
Gross Margin - 5 Yr. Avg. 43.59 52.20 52.22
EBITD Margin (TTM) 22.34 -- --
EBITD - 5 Yr. Avg 27.04 18.43 16.27
Operating Margin (TTM) 8.18 8.35 -15.11
Operating Margin - 5 Yr. Avg. 21.56 14.50 11.89
Pre-Tax Margin (TTM) 19.82 8.99 -13.67
Pre-Tax Margin - 5 Yr. Avg. 22.45 14.91 12.22
Net Profit Margin (TTM) 10.16 5.44 -17.11
Net Profit Margin - 5 Yr. Avg. 13.75 11.12 8.44
Effective Tax Rate (TTM) 48.77 21.91 21.73
Effective Tax Rate - 5 Yr. Avg. 38.75 23.94 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 7,766,711 989,839,630 878,349,382
Net Income/Employee (TTM) 788,868 115,653,467 102,474,711
Receivable Turnover (TTM) 0.94 5.43 5.49
Inventory Turnover (TTM) 5.18 2.74 3.99
Asset Turnover (TTM) 0.35 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 3.57 11.53 11.06
Return on Assets - 5 Yr. Avg. 7.63 12.44 11.85
Return on Investment (TTM) 5.99 14.34 13.80
Return on Investment - 5 Yr. Avg. 12.87 15.95 15.17
Return on Equity (TTM) 4.61 15.85 15.29
Return on Equity - 5 Yr. Avg. 10.73 16.93 16.29
  1 Year 3 Year 5 Year
Sales % -8.53 -2.92 -1.25
EPS (TTM) % -91.16 -68.65 -49.77
Dividend % 66.67 12.62 7.39
Note: Units in Millions of US Dollars

Performance for Bliss GVS Pharma Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.44 -5.94 99 93
13 Week -16.12 -8.13 99 97
26 Week -8.60 -10.05 99 92
52 Week -13.58 -17.94 99 58
YTD -22.57 -25.75 99 65
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.24%
# of Holders: 8
Total Shares Held: 6,441,059
3 Mo. Net Change: -46,515
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 1
# Reduced Positions: 2
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.